Literature DB >> 351264

Inhibitors and promoters of stone formation.

H Fleisch.   

Abstract

The understanding of the formation of urinary stones centers around three main mechanisms: the urinary concentration of stone-forming ions, the role of promoters, and the role of inhibitors of crystal formation and crystal aggregation. With respect to the promoting activity, lately emphasis has shifted from the role of the organic matrix to that of one salt inducing by epitaxy the precipitation of another salt. Among the inhibitors, it has become necessary to distinguish between those affecting crystal formation and those affecting crystal aggregation. For measuring the inhibitory activity, the various techniques and their relevance have been reviewed. It has been found that the main inhibitors for calcium phosphate and calcium oxalate precipitation are citrate, pyrophosphate, and perhaps magnesium. Those for calcium phosphate and calcium oxalate aggregation are glycosaminoglycans, pyrophosphate, and citrate. Among the synthetic inhibitors, the diphosphonates are the most powerful for both processes. The role and the therapeutic implications of these various concepts have been discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 351264     DOI: 10.1038/ki.1978.54

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  65 in total

1.  An unidentified macromolecular inhibitory constituent of calcium oxalate crystal growth in human urine.

Authors:  S Sørensen; K Hansen; S Bak; S J Justesen
Journal:  Urol Res       Date:  1990

2.  Serum, urinary and stone zinc, iron, magnesium and copper levels in idiopathic calcium oxalate stone patients.

Authors:  Irfan H Atakan; Mustafa Kaplan; Gulay Seren; Tevfik Aktoz; Hatice Gül; Osman Inci
Journal:  Int Urol Nephrol       Date:  2007       Impact factor: 2.370

3.  Chronobiology of urinary citrate excretion amongst stone-formers and healthy males from north western India.

Authors:  D Wangoo; S K Thind; G S Gupta; R Nath
Journal:  Urol Res       Date:  1991

4.  Studies of urease-induced crystallisation in undiluted human urine using the Coulter counter technique.

Authors:  Y H Wang; L Grenabo; H Hedelin; S Holmäng; S Pettersson
Journal:  Urol Res       Date:  1991

5.  Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis.

Authors:  Y Nakagawa; V Abram; J H Parks; H S Lau; J K Kawooya; F L Coe
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

Review 6.  Urolithiasis in children: current medical management.

Authors:  J Laufer; H Boichis
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

7.  Evaluation of the relative inhibitory potential of fractionated urinary macromolecules.

Authors:  R Azoury; B Goldwasser; Y Wax; S Perlberg; N Garti; S Sarig
Journal:  Urol Res       Date:  1985

8.  Crystallization conditions in urine of patients with idiopathic recurrent calcium nephrolithiasis and with hyperparathyroidism.

Authors:  J M Baumann; K Lauber; F X Lustenberger; M Wacker; E J Zingg
Journal:  Urol Res       Date:  1985

9.  Urinary mineral excretion in healthy Iranian children.

Authors:  Mohammad R Safarinejad
Journal:  Pediatr Nephrol       Date:  2002-12-21       Impact factor: 3.714

10.  Structure--activity relationship of inhibitors of hydroxyapatite formation.

Authors:  G Williams; J D Sallis
Journal:  Biochem J       Date:  1979-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.